These two reliable and high-yielding dividend payers from the healthcare sector should be on your buy list today.

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...

Merck is an industry giant that has proved time and again it can innovate for the future. Ventas has positioned itself to ...

Arcus Biosciences nears key catalysts with late-stage assets & upcoming Phase 3 data. Discover potential upside & why it's ...